VIKING GLOBAL INVESTORS LP 13D and 13G filings for Ginkgo Bioworks Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 10:16 am Unchanged | 2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 8.800% | 0 (Unchanged) | Filing |
2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 9.360% | 700,025 (+24.33%) | Filing |
2022-07-01 5:00 pm Purchase | 2022-06-28 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 2,877,103 9.700% | 1,600,725 (+125.41%) | Filing |
2022-03-04 5:21 pm Sale | 2022-03-02 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 1,276,379 4.990% | -6,297,196 (-83.15%) | Filing |
2021-10-01 5:02 pm Unchanged | 2021-09-27 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 7,573,574 22.800% | 0 (Unchanged) | Filing |
2021-09-27 5:17 pm Purchase | 2021-09-16 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 7,573,574 22.800% | 7,573,574 (New Position) | Filing |